Overview and Scope
Depyrogenated sterile empty vials refer to borosilicate glass containers with butyl-rubber stoppers and aluminum seals used for injectable drug storage. Depyrogenation is referred to as the elimination of pyrogenic substances including bacterial endotoxins through the application of heat.
Sizing and Forecast
The depyrogenated sterile empty vials market size has grown strongly in recent years. It will grow from $3.52 billion in 2023 to $3.73 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to rise in pharmaceutical manufacturing, stringent regulatory standards, focus on drug stability and purity, increase in contract manufacturing, expansion of clinical trials, introduction of high-value biologics, focus on patient safety, shift towards ready-to-use components.
The depyrogenated sterile empty vials market size is expected to see strong growth in the next few years. It will grow to $4.88 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to focus on advanced drug delivery systems, increasing regulatory emphasis on container closure integrity, rise in personalized medicine approaches, expansion of biomanufacturing facilities, focus on sustainable packaging, digitalization of supply chain management, demand for high-value oncology drugs.. Major trends in the forecast period include single-use technologies, biological drug development, quality by design (qbd) approaches, biodegradable and sustainable materials, digitalization in supply chain management, smart packaging technologies, advancements in aseptic filling technologies, collaborations and partnerships, .
To access more details regarding this report, visit the link:
Segmentation & Regional Insights
The depyrogenated sterile empty vials market covered in this report is segmented –
1) By Product: 2 ML, 5 ML, 10 ML, 20 ML, >20 ML
2) By Packaging: Glass, Plastic
3) By End User: Clinical Labs, Compounding Labs, Pharmaceutical Companies, Contract Manufacturing Organization, Distributors
North America was the largest region in the depyrogenated sterile empty vials market in 2023. The regions covered in the depyrogenated sterile empty vials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8562&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of infectious diseases across the globe is expected to propel the growth of the depyrogenated sterile empty vials market. Infectious diseases refer to conditions caused by harmful microorganisms such as bacteria, viruses, parasites, and fungi. Depyrogenated sterile vials are used for the storage of injectable medication involved in the treatment of infectious diseases. Additionally, depyrogenated sterile empty vials are also used for the collection of laboratory samples. For instance, in March 2022, according to the key facts published in 2022 by the World Health Organization (WHO), a UN agency responsible for international public health, it is estimated that there will be 1.3 to 4.0 million cholera cases every year, with 21, 000 to 143, 000 global fatalities as a result of cholera. At the end of 2021, there were an estimated 38.4 million individuals living with HIV. Therefore, the increasing prevalence of infectious diseases across the globe will drive the growth of the depyrogenated sterile empty vials market.
Key Industry Players
Major companies operating in the depyrogenated sterile empty vials market report are APG Pharma, Corning Inc., DWK Life Sciences, Nipro PharmaPackaging, Schott AG, Thermo Fisher Scientific, Gerresheimer AG, Radpharm Scientific, Stevanato Group, SGD Pharma, VWR International LLC, Merck KGaA, SiO2 Materials Science, Sigma-Aldrich, Shandong Pharmaceutical Glass Co. Ltd., Berry Global Inc., West Pharmaceutical Services Inc., Ompi Srl, AptarGroup Inc., Pacific Vial Manufacturing Inc., Adelphi Healthcare Packaging Limited, Acme Vial and Glass Company LLC, Amposan S.A., Akey Group LLC, BMT Corporation, Cangzhou Four Stars Glass Co. Ltd., Ciron Drugs & Pharmaceuticals Pvt. Ltd., Zhejiang Pharmaceutical-Packaging Co. Ltd., Verpakkingsindustrie B.V., Sisma S.p.A.
The depyrogenated sterile empty vials market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Depyrogenated Sterile Empty Vials Market will exceed USD 8 billion by 2025; as per a new research report.
Favorable government policies to support the development of innovative packaging of pharmaceutical products will stimulate depyrogenated sterile empty vials market growth during the forthcoming years.
Increasing government investment in R activities of pharmaceutical and biopharmaceutical companies to facilitate innovative product development will further favor business growth.
Additionally, increasing number of diagnostic tests being performed in research and clinical labs to diagnose infectious diseases will boost demand for depyrogenated sterile vials thereby, fostering industry growth.Get Enquiry More About This Report: http://www.marketgrowthanalysis.com/reports/sample/215Depyrogenated Sterile Empty Vials market size by Type2 ml5 ml10 ml20 mlMore than 20 mlGet Request for Toc: http://www.marketgrowthanalysis.com/reports/toc/215Depyrogenated Sterile Empty Vials market size by ApplicationsClinical LabsCompounding LabsPharmaceutical ManufacturersOthersNorth America depyrogenated sterile empty vials market accounted for more than USD 2.2 billion in 2018.
Moreover, increasing incidence of infectious and non-infectious diseases and continuous growth in the pharmaceutical and biotechnology industry will support the North America depyrogenated sterile empty vials business growth over the forecast timeframe.Some of the notable players operating in depyrogenated sterile empty vials market include APG Pharma, Corning, DWK Life Sciences, Gerresheimer, NIPRO, Radpharm Scientific, Merck, SCHOTT, Stevanato, SGD Pharma, Thermo Fisher Scientific and VWR International.Full View of Report Description: http://www.marketgrowthanalysis.com/depyrogenated-sterile-empty-vials-marketAbout us:Market Growth Analysis is one of the leading digital services provider and a result-oriented company based in Malaysia.
We are a team of enthusiastic-driven individuals with top notch skills in SEO, Market research.
Moreover, this market report also covers regional and country markets in detail.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Sterile Vials Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/sterile-vials-market/download-sampleMarket DynamicsSterility plays a vital role in hospitals, clinical labs, compounding labs, biopharmaceutical companies, and CMOs.
Any carelessness can lead to detrimental effects on human life.
Rising governmental investments in the biopharmaceutical sector and expanding research to bring new treatment further stimulated market growth.
Key companies are investing in bringing in a more advanced range of products.
The covid-19 pandemic has caused advancements in manufacturing sterile vials.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis.
